Pfizer Inc.

Stocks

PFE

US7170811035

Market Closed - NYSE Other stock markets 04:01:28 2026-06-10 pm EDT			Pre-market 08:00:00 pm
25.60 ^USD	-0.39%		25.62	+0.10%

Jun. 10	Pfizer's Risk-Reward More Balanced Ahead of 2 Key Pipeline Catalysts, RBC Capital Markets Says	MT
Jun. 10	Pfizer CEO warns German investment at risk over drug pricing policies	RE

Transcript : Pfizer Inc., Q1 2026 Earnings Call, May 05, 2026

Published on 05/05/2026 at 12:20 pm EDT - Modified on 05/27/2026 at 01:10 am EDT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good day, everyone, and welcome to Pfizer's First Quarter 2026 Earnings Conference Call. Today's call is being recorded. At this time, I would like to

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Pfizer Inc.

Jun. 10	Pfizer's Risk-Reward More Balanced Ahead of 2 Key Pipeline Catalysts, RBC Capital Markets Says	MT
Jun. 10	Pfizer CEO warns German investment at risk over drug pricing policies	RE
Jun. 10	Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon	RE
Jun. 10	Analyst recommendations: Nike, Pfizer, Hewlett Packard, Intel, The Trade Desk…
Jun. 10	RBC Upgrades Pfizer to Sector Perform from Underperform, PT is $25	MT
Jun. 09	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
Jun. 08	AstraZeneca's Obesity Pill Helps Patients Lose Weight in Midstage Trials	DJ
Jun. 08	Pfizer Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 08:00 AM
Jun. 08	Markets Ask AI for Receipts
Jun. 08	U.S. FDA Approves Pfizer?s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need	CI
Jun. 08	Pfizer Gets FDA Expanded Hympavzi Approval	DJ
Jun. 08	Pfizer Says US FDA Expands Hemophilia Drug Approval to Younger Patients	MT
Jun. 08	US FDA approves Pfizer's bleeding disorder drug for children	RE
Jun. 06	Pfizer Presents Detailed Results From Multiple Phase 2b Studies Of Berobenatide And Plans To Advance 10 Phase 3 Studies For Chronic Weight Management And Obesity-Related Comorbidities	CI
Jun. 06	Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial	RE